Brain

Harbinger Health Announces New Partnership with Leading Cancer Center to Accelerate Clinical Evidence Generation

Collaboration to include future projects developing novel tools for cancer screening and detection that leverage premier academic institution's large set…

1 year ago

Lupus Research Alliance Launches the DREAM Knowledge-Exchange Platform to Accelerate Precision Medicine in Lupus

The DREAM is the final component of the Lupus Research Alliance's Lupus Nexus, an innovative program that provides unprecedented resources…

1 year ago

REMORY: A Sea Squirt-Derived Plasmalogen Supplement Expands in the U.S. Market

REMORY: Elevate Cognitive Health with Unique Sea Squirt-Derived Plasmalogens. Now in the U.S., this Japanese-Innovated Supplement Combines EPA, DHA, and…

1 year ago

Lexaria Updates Fast-Moving GLP-1 ‘Arm’s Race’ Developments

DehydraTECH™ for GLP-1 being optimized for global pharmaceutical use KELOWNA, BC / ACCESSWIRE / November 7, 2024 / Lexaria Bioscience…

1 year ago

Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC

Partnerships will employ Vaccinex’s ActivMAb® platform for viral display of complex antigens to enable antibody discoveryROCHESTER, N.Y., Nov. 07, 2024…

1 year ago

BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING

MINNEAPOLIS, Nov. 6, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its market-leading portfolio to advance cancer…

1 year ago

Alterity Therapeutics Announces New Publication Describing Novel Mechanism of Action for ATH434

– Peer-Reviewed Publication Describes How ATH434 Uniquely Targets Excess Iron –MELBOURNE, AUSTRALIA and SAN FRANCISCO, Nov. 06, 2024 (GLOBE NEWSWIRE)…

1 year ago

Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Interim analysis for Study 1 of Essential3 Phase 3 program for ulixacaltamide in essential tremor (ET) confirmed for Q1 2025;…

1 year ago

Complete Genomics Announces Spatial Omics Distributor Agreement, Debuts Spatial Xcellerator Grant Program at SITC 2024

HOUSTON, Nov. 5, 2024 /PRNewswire/ -- At the Society for Immunotherapy of Cancer (SITC) Annual Meeting (Nov. 6-10, 2024), Complete…

1 year ago

AIRS Medical Partners With Iosei – Participações to Expand SwiftMR® Across Brazil

SEOUL, South Korea, Nov. 5, 2024 /PRNewswire/ -- AIRS Medical, a pioneer in artificial intelligence (AI)-powered diagnostic imaging solutions, has…

1 year ago